Carbogen Amcis acquires France-based Creapharm Parenterals

Carbogen Amcis acquires France-based Creapharm Parenterals

1:47 AM, 17th January 2012
Carbogen Amcis acquires France-based Creapharm Parenterals

BUBENDORF, SWITZERLAND: Carbogen Amcis AG has acquired Creapharm Parenterals, a subsidiary of France-based Creapharm Group. Formerly MP5, Creapharm Parenterals, is a contract development and manufacturing organization (CDMO) specializing in liquid, semi-solid and injectable aseptic dosage forms. As part of this acquisition, Creapharm Parenterals has changed its name to Carbogen Amcis SAS.

“This transaction further strengthens Carbogen Amcis’ service offerings, enabling us to provide customers with a complete manufacturing solution from process development to supply of pharmaceutical substances and formulated products,” said Mark Griffiths, CEO, Carbogen Amcis.

The acquisition will extend Carbogen Amcis’ comprehensive range of development and manufacturing services by adding complementary formulation, lyophilization services and sterile GMP capabilities for the fast supply of drug products, including highly-potents, for preclinical studies and clinical trials (Phase I, II & III).

“The combined capabilities and services of our two companies present a one-stop solution to pharmaceutical, biotech and virtual pharmaceutical companies looking for a single reliable partner that can provide API and drug product development for preclinical and clinical studies,” informed Maxime Laugier, Development and Projects Director, Creapharm Parenterals.

(C) WOC News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Tikkurila to cut jobs in Finland

VANTAA, FINLAND: Tikkurila has concluded the co-operation negotiations started in November 2011. The negotiations targeted all personnel groups and fu ...

Read more
Lanxess to build new production plant in Russia

LIPEZK, RUSSIA/ LEVERKUSEN, GERMANY: Rhein Chemie, subsidiary of Lanxess, at the new site in Lipezk, will produce rubber additives and release agents ...

Read more
SABIC and Sinopec to explore new business opportunities

RIYADH, SAUDI ARABIA: Saudi Basic Industries Corporation (SABIC) and the China Petroleum and Chemical Corporation (Sinopec) signed a protocol of coope ...

Read more
Georgia Gulf rejects Westlake’s acquisition proposal

ATLANTA, US: Georgia Gulf rejected Westlake Chemical’s unsolicited proposal to acquire Georgia Gulf for $30.00 per share. “After careful c ...

Read more
Solvay, Air Liquide form joint venture for fluorine gas business

BRUSSELS, BELGIUM/ PARIS, FRANCE: Solvay and Air Liquide announced that they have entered into an agreement to form a worldwide fluorine gas business ...

Read more
BASF Plant Science headquarters moved to North Carolina

LUDWIGSHAFEN, GERMANY: BASF announced that it is concentrating its plant biotechnology activities on the main markets in North and South America. The ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X